Societal costs of prescription opioid abuse, dependence, and misuse in the United States

…, AG White, M Schiller, T Waldman, JM Cleveland… - Pain …, 2011 - academic.oup.com
Objectives. The objective of this study was to estimate the societal costs of prescription opioid
abuse, dependence, and misuse in the United States. Methods. Costs were grouped into …

[HTML][HTML] Assessment, stratification, and monitoring of the risk for prescription opioid misuse and abuse in the primary care setting

…, K Lee, L Wase, CL Roland, JM Cleveland… - Journal of opioid …, 2011 - wmpllc.org
Objectives: To evaluate potential for and incidence of aberrant drug-related behaviors among
patients with chronic, moderate-to-severe pain in a primary care setting and to determine …

The Abuse Potential of Remoxy®, an Extended-Release Formulation of Oxycodone, Compared with Immediate- and Extended-Release Oxycodone

B Setnik, CL Roland, JM Cleveland, L Webster - Pain Medicine, 2011 - academic.oup.com
Objectives. Remoxy ® is a water-insoluble, highly viscous oral formulation of oxycodone
extended release (ER) currently in development. The primary objective was to determine the …

[HTML][HTML] Long-term safety, efficacy, and quality of life during adjunctive brivaracetam treatment in patients with uncontrolled epilepsy: an open-label follow-up trial

…, C Brandt, PP Quarato, AL Schulz, JM Cleveland… - Epilepsy & Behavior, 2021 - Elsevier
Objectives The primary objective of this long-term follow-up (LTFU) trial was to evaluate the
long-term safety and tolerability of brivaracetam (BRV). The secondary objective was to …

[HTML][HTML] Safety, tolerability, and efficacy of brivaracetam as adjunctive therapy in patients with focal seizures, generalized onset seizures, or Unverricht–Lundborg …

E Ben-Menachem, M Baulac, SB Hong, JM Cleveland… - Epilepsy Research, 2021 - Elsevier
This long-term open-label extension (OLE) trial was conducted to evaluate the long-term
safety and tolerability of brivaracetam (BRV) at individualized doses in patients with epilepsy …

The recurrence of digital ulcers in patients with systemic sclerosis after discontinuation of oral treprostinil

…, SL Peng, RJ McBride, JM Cleveland… - The Journal of …, 2016 - jrheum.org
Objective. Prior studies investigating the efficacy of oral treprostinil to treat digital ulcers (DU)
in systemic sclerosis (SSc)-associated Raynaud phenomenon have yielded conflicting …

Efficacy and tolerability of brivaracetam monotherapy in childhood and juvenile absence epilepsy: An innovative adaptive trial design

…, AL Schulz, F Floricel, D Morita, JM Cleveland… - Epilepsia …, 2022 - Wiley Online Library
Objective Despite introduction of several antiseizure medications over the past two decades,
treatment options for childhood absence epilepsy (CAE) and juvenile absence epilepsy (…

Safety and efficacy of midazolam nasal spray for the treatment of intermittent bouts of increased seizure activity in the epilepsy monitoring unit: a double‐blind …

DC Spencer, SR Sinha, EJ Choi, JM Cleveland… - …, 2020 - Wiley Online Library
Objective Midazolam nasal spray (MDZ‐NS) is indicated for acute treatment of intermittent,
stereotypic episodes of frequent seizure activity (ie, seizure clusters, acute repetitive seizures) …

Effect of age on phenotype and outcomes in pulmonary arterial hypertension trials

JA Rose, JM Cleveland, Y Rao, OA Minai, AR Tonelli - Chest, 2016 - Elsevier
Background In recent years, the population of patients with pulmonary arterial hypertension (PAH)
has changed dramatically, including more advanced age at diagnosis. We …

Clinical outcomes during opioid titration following initiation with or conversion to Remoxy®, an extended-release formulation of oxycodone

CL Roland, B Setnik, JM Cleveland… - Postgraduate …, 2011 - Taylor & Francis
Intra- and interpatient variability in opioid response usually necessitates opioid therapy titration
to optimally balance analgesia and side effects, whether initiating therapy or converting …